Premium
Histological features and interphase nucleolar organizer regions in hyperplastic, dysplastic and neoplastic epithelium of intrahepatic bile ducts in hepatolithiasis
Author(s) -
TERADA T.,
NAKANUMA Y.,
OHTA T.,
NAGAKAWA T.
Publication year - 1992
Publication title -
histopathology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.626
H-Index - 124
eISSN - 1365-2559
pISSN - 0309-0167
DOI - 10.1111/j.1365-2559.1992.tb00381.x
Subject(s) - hepatolithiasis , dysplasia , pathology , adenocarcinoma , bile duct , hyperplasia , carcinoma , intrahepatic bile ducts , medicine , biology , gastroenterology , cancer , hepatectomy , surgery , resection
Neoplastic transformation occurs in the intrahepatic biliary tree in hepatolithiasis. The present study aimed to clarify the neoplastic processes by correlating the histological features of the bile duct lesions with counts of interphase argyrophilic nucleolar organizer regions (AgNORs), which reflect cell proliferative activity. We studied 55 cases of hepatolithiasis and 25 normal autopsy livers. The biliary epithelial lesions in hepatolithiasis were divisible into hyperplasia, dysplasia and neoplasia. These lesions were found in bile ducts containing calculi. All cases of hepatolithiasis showed a varied degree of hyperplasia. Additionally, eight cases showed dysplasia, five non‐invasive intraductal adenocarcinoma and 10 invasive adenocarcinoma. Cases of non‐invasive and invasive carcinoma frequently harboured areas of dysplasia, and areas of dysplasia and non‐invasive carcinoma, respectively. The mean and standard deviation of the number of interphase AgNORs in the normal and abnormal biliary epithelium showed a step‐wise increase in the following order: normal (1.32±0.36), hyperplasia (1.52±0.37), dysplasia (2.28±0.56), non‐invasive carcinoma (3.23±1.00), and invasive carcinoma (3.72±0.77). These histological and cell kinetic observations suggest that, in hepatolithiasis, carcinogenesis in bile duct epithelial cells progresses in a multi‐step manner, through hyperplasia, dysplasia, non‐invasive adenocarcinoma and invasive adenocarcinoma.